{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:02:51Z","timestamp":1792188171175,"version":"4.4.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"vor","delay-in-days":1461,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1038\/ki.2013.546","type":"journal-article","created":{"date-parts":[[2014,1,15]],"date-time":"2014-01-15T08:51:18Z","timestamp":1389775878000},"page":"649-658","source":"Crossref","is-referenced-by-count":94,"title":["Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children"],"prefix":"10.1016","volume":"85","author":[{"given":"Aditi","family":"Sinha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya","family":"Bajpai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savita","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarti","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamta","family":"Puraswani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit K.","family":"Dinda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay K.","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailaja","family":"Sopory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindra M.","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Hari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind","family":"Bagga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2013.546_bb0010","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1056\/NEJM199604043341402","article-title":"Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis","volume":"334","author":"Savin","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2013.546_bb0015","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1053\/j.ajkd.2011.09.011","article-title":"Circulating mediators of focal segmental glomerulosclerosis: soluble urokinase plasminogen activator receptor in context","volume":"59","author":"Parikh","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2013.546_bb0020","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm.2411","article-title":"Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis","volume":"17","author":"Wei","year":"2011","journal-title":"Nat Med"},{"key":"10.1038\/ki.2013.546_bb0025","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1681\/ASN.2012030302","article-title":"Circulating suPAR in two cohorts of primary FSGS","volume":"23","author":"Wei","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.546_bb0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm1696","article-title":"Modification of kidney barrier function by the urokinase receptor","volume":"14","author":"Wei","year":"2008","journal-title":"Nat Med"},{"key":"10.1038\/ki.2013.546_bb0035","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/ki.2012.32","article-title":"Serum-soluble urokinase receptor concentration in primary FSGS","volume":"81","author":"Maas","year":"2012","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.546_bb0040","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.2215\/CJN.07680712","article-title":"Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report","volume":"8","author":"Bock","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.546_bb0045","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00109-012-0960-6","article-title":"The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury","volume":"90","author":"Zhang","year":"2012","journal-title":"J Mol Med (Berl)"},{"key":"10.1038\/ki.2013.546_bb0050","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1093\/ndt\/gfr612","article-title":"Amiloride off-target effect inhibits podocyte urokinase receptor expression and reduces proteinuria","volume":"27","author":"Zhang","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2013.546_bb0055","doi-asserted-by":"crossref","first-page":"e64912","DOI":"10.1371\/journal.pone.0064912","article-title":"1,25-dihydroxyvitamin D(3) inhibits podocyte uPAR expression and reduces proteinuria","volume":"8","author":"Ma","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/ki.2013.546_bb0060","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/TP.0b013e3182977ab1","article-title":"Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates","volume":"96","author":"Franco Palacios","year":"2013","journal-title":"Transplantation"},{"key":"10.1038\/ki.2013.546_bb0065","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/ki.2013.55","article-title":"Plasma soluble urokinase receptor levels are increased but do not distinguish primary from secondary focal segmental glomerulosclerosis","volume":"84","author":"Huang","year":"2013","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.546_bb0070","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/cc10037","article-title":"Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients","volume":"15","author":"Koch","year":"2011","journal-title":"Crit Care"},{"key":"10.1038\/ki.2013.546_bb0075","doi-asserted-by":"crossref","first-page":"R149","DOI":"10.1186\/cc11463","article-title":"Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor","volume":"16","author":"Giamarellos-Bourboulis","year":"2012","journal-title":"Crit Care"},{"key":"10.1038\/ki.2013.546_bb0080","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1086\/428854","article-title":"Plasma concentrations of soluble urokinase-type plasminogen activator receptor are increased in patients with malaria and are associated with a poor clinical or a fatal outcome","volume":"191","author":"Ostrowski","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1038\/ki.2013.546_bb0085","doi-asserted-by":"crossref","first-page":"e51698","DOI":"10.1371\/journal.pone.0051698","article-title":"Inflammation in HIV-infected patients: impact of HIV, lifestyle, body composition and demography: A cross sectional cohort study","volume":"7","author":"Langkilde","year":"2012","journal-title":"PLoS One"},{"key":"10.1038\/ki.2013.546_bb0090","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/MCG.0b013e31822da19d","article-title":"Soluble urokinase plasminogen activator receptor is associated with progressive liver fibrosis in hepatitis C infection","volume":"46","author":"Berres","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"10.1038\/ki.2013.546_bb0095","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s10753-010-9195-2","article-title":"Urine suPAR levels compared with plasma suPAR levels as predictors of post-consultation mortality risk among individuals assumed to be TB-negative: a prospective cohort study","volume":"33","author":"Rabna","year":"2010","journal-title":"Inflammation"},{"key":"10.1038\/ki.2013.546_bb0100","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/MAJ.0b013e3181b922a4","article-title":"Hyperfibrinolysis, uPA\/suPAR system, kynurenines, and the prevalence of cardiovascular disease in patients with chronic renal failure on conservative treatment","volume":"339","author":"Pawlak","year":"2010","journal-title":"Am J Med Sci"},{"key":"10.1038\/ki.2013.546_bb0105","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3349\/ymj.2010.51.4.519","article-title":"Tumor necrosis factor (TNF-alpha) and C-reactive protein (CRP) are positively associated with the risk of chronic kidney disease in patients with type 2 diabetes","volume":"51","author":"Yeo","year":"2010","journal-title":"Yonsei Med J"},{"key":"10.1038\/ki.2013.546_bb0110","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/sji.12082","article-title":"Fibroblast growth factor 23, hepatocyte growth factor, interleukin-6, high sensitivity c-reactive protein and soluble urokinase plasminogen activator receptor. Inflammation markers in chronic hemodialysis patients?","volume":"78","author":"Almroth","year":"2013","journal-title":"Scand J Immunol"},{"key":"10.1038\/ki.2013.546_bb0115","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1093\/clinchem\/43.10.1868","article-title":"ELISA determination of soluble urokinase receptor in blood from healthy donors and cancer patients","volume":"43","author":"Stephens","year":"1997","journal-title":"Clin Chem"},{"key":"10.1038\/ki.2013.546_bb0120","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jmv.21114","article-title":"Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy","volume":"80","author":"Andersen","year":"2008","journal-title":"J Med Virol"},{"key":"10.1038\/ki.2013.546_bb0125","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1046\/j.1523-1755.2001.00719.x","article-title":"Release of urokinase plasminogen activator receptor during urosepsis and endotoxemia","volume":"59","author":"Florquin","year":"2001","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.546_bb0130","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1046\/j.1523-1755.2003.00261.x","article-title":"Expression of urokinase plasminogen activator and its receptor during acute renal allograft rejection","volume":"64","author":"Roelofs","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.546_bb0135","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.7314\/APJCP.2012.13.6.2887","article-title":"Utility of serum and urine uPAR levels for diagnosis of breast cancer","volume":"13","author":"Soydinc","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1038\/ki.2013.546_bb0140","first-page":"7126","article-title":"Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy","volume":"60","author":"Mustjoki","year":"2000","journal-title":"Cancer Res"},{"key":"10.1038\/ki.2013.546_bb0145","first-page":"717","article-title":"Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance","volume":"79","author":"Sier","year":"1999","journal-title":"Lab Invest"},{"key":"10.1038\/ki.2013.546_bb0150","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/eci.12070","article-title":"Soluble urokinase plasminogen activator receptor, C-reactive protein and triglyceride are associated with heart rate variability in non-diabetic Danes","volume":"43","author":"Intzilakis","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"10.1038\/ki.2013.546_bb0155","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.trsl.2013.07.003","article-title":"Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus","volume":"162","author":"Enocsson","year":"2013","journal-title":"Transl Res"},{"key":"10.1038\/ki.2013.546_bb0160","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.546_bb0165","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1542\/peds.114.2.S2.555","article-title":"The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents","volume":"114","author":"National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents","year":"2004","journal-title":"Pediatrics"},{"key":"10.1038\/ki.2013.546_bb0170","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification","volume":"39","author":"National Kidney Foundation","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2013.546_bb0175","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ki.1981.209","article-title":"Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity","volume":"20","author":"International Study of Kidney Disease in Children","year":"1981","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.546_bb0180","first-page":"203","article-title":"Management of steroid sensitive nephrotic syndrome: revised guidelines","volume":"45","author":"Indian Pediatric Nephrology Group, Indian Academy of Pediatrics","year":"2008","journal-title":"Indian Pediatr"},{"key":"10.1038\/ki.2013.546_bb0185","first-page":"35","article-title":"Management of steroid resistant nephrotic syndrome","volume":"46","author":"Indian Society of Paediatric Nephrology","year":"2009","journal-title":"Indian Pediatr"},{"key":"10.1038\/ki.2013.546_bb0190","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1136\/bmj.281.6251.1336","article-title":"Statistics and ethics in medical research-III: How large a sample?","volume":"281","author":"Altman","year":"1980","journal-title":"Br Med J"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815562601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815562601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T01:31:03Z","timestamp":1597368663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815562601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0085253815562601"],"URL":"https:\/\/doi.org\/10.1038\/ki.2013.546","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718240612.793493301","asserted-by":"object"}]},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}